Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: Rationale and design of the PREVENT-HF study

Europace

Volumn 9, Issue 6, 2007, Pages 442-446

  de Teresa, Eduardo ^a   Gómez Doblas, Juan José ^a   Lamas, Gervasio ^b   Alzueta, Javier ^a   Fernández Lozano, Ignacio ^c   Cobo, Erik ^d   Navarro, Xavier ^e   Navarro López, Francisco ^f   Stockburger, Martin ^g  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^e SA   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Biventricular pacing; Cardiac resynchronization; Heart failure; Right ventricular pacing

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; OXYGEN;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GERMANY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART SURGERY; HEART VENTRICLE PACING; HUMAN; INTERMETHOD COMPARISON; ITALY; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; MORTALITY; MULTICENTER STUDY; OXYGEN CONSUMPTION; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPAIN;

BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; GERMANY; HUMANS; ITALY; MULTICENTER STUDIES; PACEMAKER, ARTIFICIAL; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SPAIN; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34547900219     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum064     Document Type: Article

References (29)

1. Lupi G, Sassone B, Badano L, Peraldo C, Gaddi O, Sitges M et al. on behalf of the Ablate and Pace in Atrial. Fibrillation (APAF) Pilot Echocardiographic Trial Investigators. Effects of right ventricular pacing on intra-left ventricular electromechanical activation in patients with native narrow QRS. Am J Cordial 2006;98:219-22.
2. Faber L, Lamp B, Hering D, Bogunovic N, Scholtz W, Heintze J et al. Analysis of inter- and intraventricular asynchrony by tissue Doppler echo-cardiography. Z Kardiol 2003;92:994-1002.
3. Badano LP, Gaddi O, Peraldo C, Lupi G, Sitges M, Parthenakis F et al. Left ventricular electromechanical delay in patients with heart failure and normal QRS duration and in patients with right and Left bundle branch block. Europace 2007;9:41-7.
4. Caso P, D'Andrea A, Martiniello AR, Severino S, Cloppa C, Lengo R et al. Myocardial systolic activation delay in patients with left bundle branch block and either normal or impaired left ventricular function. Echocardiography 2006;23:14-23.
5. De Teresa E, Chamorro JL, PuLpon LA, Ruiz C, Balton IR, Alzueta J et al. An even more physiological pacing: Changing the sequence of ventricular activation. In: Steinbach K, Gtogar D, Laszkovics; A et al., eds. Cardiac Pacing. Proceedings of the VIIth World Symposium on Cardiac Pacing. Darmstadt: Steinkopff Verlag; 1983. p395-400.
6. Barold SS, Cazeau S. The first reports of electrical multisite ventricular activation in humans. Pacing Clin Electrophysiol 2000;23:2117-9.
7. Abraham Wr, Fisher WG, Smith AL, Deturgio DB, Leon AR, Loh E et al. MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. New Engl J Med 2002;346:1845-53.
8. Cleland J, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352 1539-49.
9. Bristow MR, Saxon LA, Boehmer J, Krueger 5, Kass DA, De Marco T et al. for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantabte defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
10. Brunner M, Olschewski M, Geibel A, Bode C, Zehender M. Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur Heart J 2004;25 88-95.
11. Sweeney MO, Heilkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-7.
12. Witkoff BL, Cook JR, Epstein AE, Greene HL, Hatistrom AP, Hsia H et al. Dual Chamber and VVI Implantable Defibritiator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The dual chamber and VVI implantable defibrillator (DAVID) Trial. JAMA 2002;288 3115-23.
13. Simantirakis EN, Vardakis KE, Kochiadakis GE, Manias EG, Igoumenidis NE, Brignole M et al. Left ventricutar mechanics during right ventricular apical or Left ventricular-based pacing in patients with chronic atrial. fibrillation after atrioventricular junction ablation. J Am Coll Cardiol 2004;43:1013-8.
14. Sharma AD, Rizo-Patron C, Hallstrom AP, O'Neill GP, Rothbart S, Martins JB et al., DAVID Investigators. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2005;2 830-4.
15. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R et al. Mode selection trial in sinus-node dysfunction. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346:1854-62.
16. Shukla HH, Hellkamp AS, James EA, Ftaker GC, Lee KL, Sweeney MO et al. on behalf of the Mode Selection Trial (MOST) Investigators. Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration. Heart Rhythm 2005;2:245-251.
17. Gomes JA, Damato AN, Akhtar M, Dhatt MS, Calon AH, Reddy CP et al. Ventricular septak motion and left ventricular dimensions during abnormal ventricular activation. Am J Cardiol 1977;39:641-50.
18. Miyazawa K, Arai T, Shirato K, Haneda T, Ikeda S. Regional contraction patterns of the left ventricle during ventricular pacing. Tohoku J Exp Med 1977;122:167-74.
19. Xiao HB, Brecker SJ, Gibson DG. Differing effects of right ventricular pacing and left bundle branch block on left ventricular function. Br Heart J 1993;69:166-73.
20. Lee MA, Dae MW, Langberg JJ, Griffin JC, Chin MC, Finkbeiner WE et al. Effects of Long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology. J Am Coll Cardiol 1994;24:225-32.
21. Simantirakis EN, Prassopoulos VK, Chrysostomakis SI, Kochiadakis GE, Koukouraki SI, Lekakis JP et al. Effects of asynchronous ventricular activation on myocardial adrenergic innervation in patients with permanent dual-chamber pacemakers; an 1(123)-metaiodobenzylguanidine cardiac scintigraphic study. Eur Heart J 2001;22:323-32.
22. Nakata T, Miyamoto K, Doi A, Sasao H, Wakabayashi T, Kobayashi H et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 1995;5:579-90.
23. Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamadan MH et al. on behalf of the PAVE study group. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16:1160-5.
24. Kindermann M, Hennen B, Jung J, Geisel J, Böhm M, Fröhlig G. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction. J Am Coll Cardiol 2006;47:1927-37.
25. Anand IS, Fiorea VG, Fisher L. Surrogate end points in heart failure. J Am Coll Cardiol 2002;39:1414-21.
26. Greenberg B, Quiñónez MA, Koilpillai C, Limacher M, Shindler D, Benedict C et al. for the SOLVD Investigators Effects of Long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiographic substudy. Circulation 1995;91:2573-81.
27. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-6.
28. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:685-91.
29. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F Komajda M et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005). The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-40.